The round was led by IVP, accelerating the company's mission to make advocacy a standard part of care for every patient in the United States. The Series C values Solace at over $1 billion and reflects growing consensus that healthcare advocacy is no longer optional as costs rise and systems fracture.

本轮融资由IVP领投，加速了该公司使倡导成为美国每位患者护理标准部分的使命。C轮融资对Solace的估值超过10亿美元，反映出医疗保健倡导已不再是可选项的共识日益增强，因为成本不断上升，体系日益分裂。

The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures..

本轮融资还吸引了现有投资者 Menlo Ventures、SignalFire、Torch Capital、Inspired Capital 和 RiverPark Ventures 的参与。

Solace Health (Solace) is a digital platform that connects patients with expert healthcare advocates who navigate the healthcare system on their behalf, improving outcomes and reducing costs. Founded in 2022 by Jeremy Gurewitz and Sara Sargent after their own experiences with a fragmented healthcare system, Solace empowers patients to take control of their care journeys.

Solace Health（Solace）是一个数字平台，将患者与专业的医疗倡导者联系起来，这些倡导者代表患者导航医疗系统，改善结果并降低成本。该公司由杰里米·古雷维茨和莎拉·萨金特于2022年创立，源于他们自身在碎片化医疗系统中的经历，Solace致力于帮助患者掌控自己的护理旅程。

Solace advocates coordinate appointments, manage treatment plans, and ensure continuity of care, helping patients and families overcome the obstacles that stand between them and better outcomes..

Solace的倡导者们协调预约、管理治疗计划并确保护理的连续性，帮助患者及其家属克服阻碍他们获得更好结果的障碍。